Bryan, Garnier & Co ranks #1 in public takeovers on NYSE Euronext
Paris, November 23rd, 2012 - With the recent completion of successful squeeze outs on Metrologic Group on behalf of the Carlyle Group and ESR for Osiatis, Bryan, Garnier & Co confirms its expertise and leadership on public offers on NYSE Euronext, with a 40% market share on its core sectors over the last two years.
For the period 2011-2012, Bryan Garnier ranks number one investment bank for public offers on NYSE Euronext with an involvement in nine transactions. Bryan Garnier has built a strong franchise in the segment, advising buyers in the acquisition of listed companies, as well as target companies or selling shareholders.
As an advisor to the initiator, Bryan Garnier successfully advised industrial buyers (Biomerieux, Santen, Osiatis) as well as international financial investors (Thoma Bravo, the Carlyle Group) in transactions that all led to an ultimate squeeze-out of the targets. In addition, as an advisor to the target companies or reference shareholders (Metrologic Group, Leguide.com, Modelabs Group, Press Index), Bryan Garnier played an instrumental role in advising the stakeholders in their negotiations with the bidders (block sale, offer price), the definition of the transaction structure and the coordination of the process, including interactions with market authorities and valuation experts.
Olivier Beaudouin, Managing Director Corporate Finance: "the current economic environment is favourable to transactions on listed companies as shareholders are looking for liquidity while valuations remain attractive for buyers, particularly in Europe, as compared to the US or emerging markets. Buyers from different horizons (industrial groups, private equity firms) are increasingly looking at opportunities with the objective of taking targets private. In that context, the role of the financial advisor is key to explaining the country specific mechanism of public take-overs and to defining strategies and structures that will maximise the chances of achieving the ultimate squeeze-out of the target.
Our expertise and commitment has been particularly valuable to foreign US financial investors such as Thoma Bravo or The Carlyle Group who had no or limited prior experience of take private situations on NYSE Euronext, and who have heavily relied, from a distance, on our expertise to conduct the successful execution of such transactions".
Virginie Lazes, Managing Partner, Head of Corporate Finance added: "This series of take private transactions confirms Bryan Garnier's positioning as a full service specialist investment bank across M&A and Capital Markets , and further demonstrates our ability to support international industrial and private equity clients on a comprehensive scope of corporate finance transactions".
Bryan Garnier contacts:
Olivier Beaudouin - Managing Director - Corporate Finance
+33 1 56 68 75 35 firstname.lastname@example.org
Christian Finan - Director - Equity Capital Markets
+33 1 56 68 75 30 email@example.com
Vincent Gasné - Vice-President - Corporate Finance
+33 1 56 68 75 93 firstname.lastname@example.org
About Bryan, Garnier & Co www.bryangarnier.com
Bryan, Garnier & Co is an independent investment bank specialising in European Healthcare, TMT, Specialty Retail and Renewable Energies growth companies. The firm is focused on three major activities: Equity Research & Brokerage, Asset Management and Corporate Finance.
With 150 professionals based in London, Paris, New Delhi, New York and Geneva, Bryan, Garnier & Co has for over ten years offered the range of services and expertise of top-tier investment banks, yet has the level of attention to clients of a boutique.
Bryan, Garnier & Co is authorised and regulated by the Financial Services Authority (FSA) in the United Kingdom, and is member of London Stock Exchange and Euronext, Alternext Listing Sponsor, and is active on all European Capital Markets.